BIOMAT Database Logo BIOMAT Database Logo

Recent advance in the treatment of diabetic nephropathy: angiotensin I converting enzyme (ACE) inhibitors. 1991

M Marre
Unite de Diabetologie Service de Medecine, Centre Hospitalier Regional Universitaire, Angers, France.

UI MeSH Term Description Entries
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D004656 Enalapril An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. Enalapril Maleate,MK-421,MK421,Renitec,Renitek,MK 421,Maleate, Enalapril
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000419 Albuminuria The presence of albumin in the urine, an indicator of KIDNEY DISEASES. Albuminurias

Related Publications

M Marre
[Angiotensin-converting enzyme inhibitors in the treatment of diabetic nephropathy].
September 1994, Deutsche medizinische Wochenschrift (1946),
M Marre
Angiotensin-converting enzyme inhibitors in diabetic nephropathy.
March 1993, The Annals of pharmacotherapy,
M Marre
Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers in diabetic nephropathy? ACE inhibitors.
January 2004, Ethnicity & disease,
M Marre
Angiotensin converting enzyme inhibitors and diabetic nephropathy.
February 1992, BMJ (Clinical research ed.),
M Marre
Angiotensin converting enzyme (ACE) inhibitors.
January 1982, Annual review of pharmacology and toxicology,
M Marre
[Usefulness of angiotensin converting enzyme inhibitors in the treatment of diabetic nephropathy].
March 1988, Medicina clinica,
M Marre
Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.
April 1998, Kidney international,
M Marre
Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
January 2002, Ethnicity & disease,
M Marre
Angiotensin-converting enzyme inhibitors and progression of diabetic nephropathy.
April 1993, Annals of internal medicine,
M Marre
[Angiotensin converting enzyme (ACE) gene polymorphism in a diabetic cohort and diabetic nephropathy].
May 1999, Harefuah,
Copied contents to your clipboard!